.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer last year for a whopping $43 b...
.On the heels of a stage 3 succeed that neglected to make an impression on clients, Ironwood Pharmac...
.Do not quit Monte Rosa Rehabs now. The Boston-based biotech is actually enjoying after authorizing ...
.Invite to this week's Chutes & Ladders, our summary of notable management hirings, shootings and...
.Commemorating his business's upsized initial public offering (IPO), Septerna chief executive office...
.AbbVie has returned to the resource of its antipsychotic goliath Vraylar in search of yet another b...
.GenSight Biologics is weeks far from running out of loan. Once more. The biotech simply possesses s...
.Monopar Rehabs is recuperating a medicine from the scrap heap of AstraZeneca's unusual disease pipe...
.Along with new data out on Arcus Biosciences' speculative HIF-2a prevention, one team of experts es...
.After developing a genetics treatment partnership along with Dyno Therapies in 2020, Roche is actua...
.Lundbeck is slashing the book market value of its own $250 million Abide Therapeutics acquistion in...
.The assimilation of real-world data (RWD) into protocol usefulness and site selection has emerged a...
.At this year's Ferocious Biotech Peak in Boston, we caught up with forerunners in the biotech field...
.Merck & Co. is actually putting down $30 million beforehand to acquire Yale spinout Modifi Biosc...
.Alpha-9 Oncology has increased a $175 thousand set C cycle to stake its own clinical-stage radiopha...
.Eye medication manufacturer Ocuphire Pharma is actually getting genetics treatment developer Piece ...
.Roche's severe cough plan has sputtered to a stop. The drugmaker, which axed the program after the ...
.Gilead Sciences and also Merck & Co. have actually led their once-weekly HIV combo treatment pas...
.Lykos Rehabs might possess dropped three-quarters of its own staff back the FDA's turndown of its o...
.Septerna might be actually yet to divulge "any purposeful clinical data," but the biotech clearly a...